Leading RNA editing to treating disease
Stanford, CA
Joined August 2015
- Tweets211
- Following262
- Followers575
- Likes362
1/3 Super excited to present our work on RNA editing and sensing through the lens of human genetics of autoimmune and inflammatory diseases at #ASHG2024 in the Featured Symposium of #ADAR #RNAediting, Thursday Nov 7th 8:00-9:30am.
eppro02.ativ.me/appinfo.php?… #ASHG24
2/3 I look forward to meeting old and new friends! If you are interested in our work (exemplified by this paper) and seeking postdoc or collaboration opportunities, please feel free to DM or email me to schedule time to meet up!
nature.com/articles/s41586-0…
3/3 I’d be also happy to meet and discuss what ADAR can do as a novel modality for therapeutic RNA base editing and how human genetics plays a crucial role for the target discovery etc. (Disclosure: I co-founded AIRNA, a company in this exciting space.)
airna.com
Excited about the additional $60M raise of AIRNA - kudos to the team! I never expected the amazing potential to help patients when I encountered this bizarre biology many years ago. More to come about ADAR, a truly one of its kind enzyme!
businesswire.com/news/home/2…
Congratulations Xiaojing and the team! It’s amazing to watch all the ADAR-related developments. I cannot wait to see how things unfold and what the next ADAR-related invention will be! #ADAR #RNAediting
Radar Tx is de-stealthed today! It's been so great working (or rather, tagging along) with co-founders, @EerikKaseniit, Sophia Lugo, and Jim Collins. We've assembled a stellar research team, forging ahead with new designs. We are still hiring more. endpts.com/startup-launches-…
Excited to be part of this symposium to celebrate the extraordinary career of my PhD co-advisor Gary Stormo @gdstormo! I look forward to seeing Gary and other mentors and friends!
The Stormo Symposium on Computational Biology is open for registration! Join us and our exceptional group of speakers on “History and Current Developments in Computational Biology”. Don't miss this incredible event @WashUGenetics Please share and register! genetics.wustl.edu/the-storm…
Honored to be part of this exciting webinar organized by Bryan Harada @structural_biol. I will focus on dsRNA editing mediated by ADAR1 and dsRNA sensing mediated by MDA5 and PKR. #ADAR
Free Cell Press webinar, RNA sensing in immunity, w/ speakers Sun Hur @harvardmed @BostonChildrens, Stacy Horner @DukeMedSchool @TheHornerLab & Jin Billy Li @Stanford, Nov 15, 12:00 pm ET. hubs.li/Q026YThd0
Billy Li retweeted
Online Now: ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation dlvr.it/Sx0J0d
This preprint finds a nice home @MolecularCell. We hope that the mechanistic understanding of how ADAR1 safeguards cellular dsRNAs will provide insights for therapeutic developments. #RNAediting #ADAR
authors.elsevier.com/a/1hsoa…
Delighted to share a new @biorxivpreprint from my lab @stanford and Carl Walkley’s lab @SVIResearch, led by amazing Shi-Bin Hu and @jacki_hf . We provide clear mechanisms for a standing question re ADAR1’s editing-dependent and independent role. #ADAR
biorxiv.org/content/10.1101/…
I cannot ask for a better collaborator than Carl Walkley @SVIResearch and a nicer team spearheaded by Shibin Hu and @jacki_hf.
Thank you Rohini for the heavy lifting of writing this nice review! A lot has been happening in the RNA editing field.
Greatly enjoyed writing this advanced review on the therapeutic potential of #RNA #editing, ranging from #cancer #immunotherapy to #viral (focusing on #SARSCoV2) #infections. Part of #postdoc research at #Stanford. Congratulations to all the co-authors! wires.onlinelibrary.wiley.co…
Thrilled to be on this exciting journey! It is surreal to have this opportunity to translate the fundamental discoveries (that my co-founder Thorsten Stafforst pioneered), with the help from a passionate team of executives, scientists, and investors. endpts.com/arch-backed-start…
Huge congratulations to Qin for the incredible milestone! Feeling really proud! Penn is lucky to have you!
Feeling incredibly thrilled to announce that in January 2024, I'll be joining @PennGenetics and @UPenn_I3H as an Assistant Professor! My lab will study the genetic basis of immune recognition of RNA and its role in health and disease. Please reach out or DM if you are interested.
Congratulations Jacki, Carl and the team! As many pay attention to the role of ADAR1 in cancer, this is a very important message showing that ADAR1 upregulation in cancers is not causal, but correlative.
Happy to share the new preprint from the Walkley lab where we directly tested whether increasing levels of #ADAR1 and A-to-I editing levels in vivo could promote #cancer formation or progression. (1/n)
@SVIResearch @AlistairChalk
biorxiv.org/content/10.1101/…
This is indeed THE result worth emphasizing @jacki_hf . It is the type of “black & white” experiments we seem to see less as biology appears more complex.
Delighted to share a new @biorxivpreprint from my lab @stanford and Carl Walkley’s lab @SVIResearch, led by amazing Shi-Bin Hu and @jacki_hf . We provide clear mechanisms for a standing question re ADAR1’s editing-dependent and independent role. #ADAR
biorxiv.org/content/10.1101/…
MDA5 and PKR are unequivocally the primary in vivo effectors of fatal autoinflammation following the loss of ADAR1p150. Other dsRBPs such as ZBP1 also play functional roles in the context of ADAR1, but future work is needed to dissect the mechanisms to reveal a full picture.